Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 30, 2024
Read More Apparatus Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer! Nov 22, 2024
Read More Apparatus World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy! Nov 29, 2024
Read More Disease Clinical Trial Treatment Restores Health To Rare Uterine Cancer Patient Nov 29, 2024
